NRX Pharmaceuticals, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2018 | 1.3% | 1.3% | 0.1% |
| FY2019 | -8.4% | -8.4% | 1.3% |
| FY2020 | 118.3% | 118.3% | -1,760.5% |
| FY2021 | -447.3% | -447.3% | -284.3% |
| FY2022 | -536.6% | -388.6% | -154.0% |
| FY2023 | 257.0% | 1,172.2% | -412.2% |
| FY2024 | 108.2% | 108.2% | -688.2% |
| FY2025 | 179.6% | 179.6% | -220.9% |